ARTICLE | Clinical News
Adipiplon: Phase II/III halted
July 21, 2008 7:00 AM UTC
Neurogen suspended a double-blind, placebo-controlled, crossover U.S. Phase II/III trial comparing 6 mg and 9 mg of oral adipiplon to placebo or 12.5 mg Ambien CR after adipiplon showed a higher-than...